Trials / Completed
CompletedNCT03645668
Efficacy and Pharmacokinetics of Meropenem in Severe Septic Patients
Efficacy and Pharmacokinetics of Meropenem in Different Administration for Patients With Severe Sepsis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The experimental and control group were used different administration of Meropenem through monitoring the Meropenem plasma concentration and clinical data
Detailed description
This study is a prospective, randomized controlled trial, which the subjects were severe sepstic patients for selecting Meropenem as antimicrobial drugs. The experimental and control group were used different administration of Meropenem through monitoring the Meropenem plasma concentration and clinical data, eventually demonstrate the effecacy and safety of Meropenem in patients with severe infection and optimize the best clinical practice for antimicrobial agents.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Meropenem Injection | Different administration types between two groups |
Timeline
- Start date
- 2018-01-30
- Primary completion
- 2019-11-14
- Completion
- 2019-12-14
- First posted
- 2018-08-24
- Last updated
- 2020-03-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03645668. Inclusion in this directory is not an endorsement.